A Worldwide Antihistamine-Refractory Chronic Urticaria Patient Evaluation in Latin America and Canada (AWARE-LACan)
NCT02626221
·
clinicaltrials.gov ↗
COMPLETED
Status
497
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Urticaria
Interventions
OTHER:
Non Interventional Study
Sponsor
Novartis Pharmaceuticals